84 related articles for article (PubMed ID: 24340465)
1. Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis--experience with 3 patients.
Mahajan R; Kanwar AJ
Skinmed; 2013; 11(5):269-71. PubMed ID: 24340465
[TBL] [Abstract][Full Text] [Related]
2. Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ang CC; Tay YK
Int J Dermatol; 2011 Dec; 50(12):1570-8. PubMed ID: 22098009
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
Pallesen KA; Robinson S; Toft P; Andersen KE
Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
[No Abstract] [Full Text] [Related]
4. Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected].
de Sica-Chapman A; Williams G; Soni N; Bunker CB
Br J Dermatol; 2010 Apr; 162(4):860-5. PubMed ID: 19912214
[TBL] [Abstract][Full Text] [Related]
5. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
Goulden V; Goodfield MJ
Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680
[TBL] [Abstract][Full Text] [Related]
6. Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor.
Winfred RI; Nanda S; Horvath G; Elnicki M
South Med J; 1999 Sep; 92(9):918-20. PubMed ID: 10498172
[TBL] [Abstract][Full Text] [Related]
7. Etanercept therapy for toxic epidermal necrolysis.
Paradisi A; Abeni D; Bergamo F; Ricci F; Didona D; Didona B
J Am Acad Dermatol; 2014 Aug; 71(2):278-83. PubMed ID: 24928706
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.
Primka EJ; Camisa C
J Am Acad Dermatol; 1997 May; 36(5 Pt 2):815-8. PubMed ID: 9146556
[TBL] [Abstract][Full Text] [Related]
10. Management of a patient with advanced AIDS and toxic epidermal necrolysis using human growth hormone and G-CSF.
Bae RJ; Orgill DP; DeBiasse MA; Demling R
AIDS Patient Care STDS; 1997 Jun; 11(3):125-9. PubMed ID: 11361785
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
12. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
Upadya GM; Ruxana K
Indian J Med Sci; 2009 Oct; 63(10):461-3. PubMed ID: 19901485
[TBL] [Abstract][Full Text] [Related]
14. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.
Hirahara K; Kano Y; Sato Y; Horie C; Okazaki A; Ishida T; Aoyama Y; Shiohara T
J Am Acad Dermatol; 2013 Sep; 69(3):496-8. PubMed ID: 23957982
[No Abstract] [Full Text] [Related]
16. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
Kaur-Knudsen D; Zachariae C; Thomsen SF
Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
[TBL] [Abstract][Full Text] [Related]
17. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
Hazar V; Ongun H; Yeşilipek MA; Yeğin O
Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
[TBL] [Abstract][Full Text] [Related]
18. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S; Fouchard N; Bertocchi M; Roujeau JC; Revuz J; Wolkenstein P
J Invest Dermatol; 2000 Aug; 115(2):149-53. PubMed ID: 10951229
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.
Robak E; Robak T; Góra-Tybor J; Chojnowski K; Strzelecka B; Waszczykowska E; Sysa-Jedrzejowska A
J Med; 2001; 32(1-2):31-9. PubMed ID: 11321886
[TBL] [Abstract][Full Text] [Related]
20. The use of granulocyte colony-stimulating factor after liver transplantation.
Foster PF; Mital D; Sankary HN; McChesney LP; Marcon J; Koukoulis G; Kociss K; Leurgans S; Whiting JF; Williams JW
Transplantation; 1995 Jun; 59(11):1557-63. PubMed ID: 7539958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
